• Home
• About us
• Contact

• News
• People
• Products
• Deals
• Organisations

• » Follow us on twitter!
• » Get Free Newsletter!

Advertisement

Organisation › Details

Evolva (Group)

Evolva is an international, innovative synthetic biology company with a world-class research platform. Evolva strives to improve people's lives by applying its technology and other resources to the discovery and development of new products and processes that benefit the health, well-being and financial economy of patients, consumers and partner companies around the world. Evolva uses biosynthetic and evolutionary technologies to artificially create and optimise small molecule compounds and their production routes. Our approach differs from that of the mainstream in the pharmaceutical and chemical industries. We have discovery partnerships ongoing both in pharma and in nutrition. In addition we have a pipeline of promising compounds aimed at infectious and cardio-renal indications. *

 

	Start	2001-01-01 established
	Industry	food ingredient
	Industry 2	resveratrol
	Person	Waddington, Simon (Evolva 201707–201807 CEO before COO before Abunda Nutrition CEO RESIGNED 7/18)
	Person 2	Hoetmer, Gerard (Corbion 201306 CEO)
	Region	Reinach BL
	Country	Switzerland
	Street	23 Duggingerstr.
	City	4153 Reinach BL
	Tel	+41-61-485-2000
		Address record changed: 2018-07-24
Basic data	Employees	D: 101 to 500 (2014-12-31)
	Currency	CHF
	Annual sales	9,600,000 (revenue, total, consolidated (2016) 2016-12-31)
	Profit	-35,800,000 (2016-12-31)
	Cash	47,500,000 (2016-12-31)
		* Document for �About Section�: Evolva Holding S.A.. (5/2/11). "Press Release: Evolva Appoints Norbert Bender as Chief Medical Officer". Reinach.
		Record changed: 2018-09-12

Advertisement

More documents for Evolva (Group)

• [1] Evolva Holding S.A.. (7/10/18). "Press Release: Evolva Announces Oliver Walker to Succeed Simon Waddington as CEO"....
• [2] Evolva Holding S.A.. (10/26/17). "Press Release: Evolva Announces Final Terms of Proposed Capital Increase [Not for release in US, CA, JP or AU or any jurisdiction where unlawful]"....
• [3] Evolva Holding S.A.. (8/30/17). "Press Release: Evolva Announces Major Restructuring for Next Phase of Its Development"....
• [4] Evolva Holding S.A.. (8/14/17). "Press Release: Evolva Announces Financial Results for the First Half of 2017"....
• [5] Evolva Holding S.A.. (7/6/17). "Press Release: Neil Goldsmith Stepping Down as CEO and Board Member of Evolva"....
• [6] Evolva Holding S.A.. (6/12/17). "Press Release: Scott Fabro to Join Evolva as Chief Commercial Officer"....
• [7] Evolva Holding S.A.. (4/20/17). "Press Release: Gerard Hoetmer, Formerly at Unilever and Corbion, Proposed to Succeed Sir Tom McKillop as Evolva Chairman". Switzerland....
• [8] Evolva Holding S.A.. (11/29/16). "Press Release: Evolva Appoints Oliver Walker as CFO. Strong Track Record as CFO of Nobel Biocare, Sonova and Stratec"....
• [9] Acesion Pharma ApS. (11/15/16). "Press Release: Acesion Pharma Recruits an Experienced Life Science Chief Financial Officer". Copenhagen....
• [10] Evolva Holding S.A.. (10/27/16). "Press Release: ERS Genomics and Evolva Sign License Agreement on CRISPR-Cas9 Genome Editing Patents for Industrial Applications". Dublin & Reinach....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2019. Made in Germany.